Key result
Type 2 MI is linked to ~5-point smaller health status improvement at 4 months vs type 1 MI.
Why the study?
Does health status recovery (measured by EQ-5D-5L VAS, angina, physical function, frailty, fatigue, and depression) over 4 months differ between patients hospitalized with type 2 myocardial infarction compared to type 1 myocardial infarction?
Cohort (n=149)
No
Does health status recovery (measured by EQ-5D-5L VAS, angina, physical function, frailty, fatigue, and depression) over 4 months differ between patients hospitalized with type 2 myocardial infarction compared to type 1 myocardial infarction?
Patients recovering from type 2 MI experience significantly smaller improvements in overall health status and persistently worse physical function and frailty over 4 months compared with type 1 MI, highlighting the need for multidimensional post-discharge interventions beyond angina management.
Answers are grounded in this paper and cite their sources.
Type 2 MI recovery shows smaller health status gains; hypothesis-generating for targeted interventions addressing frailty and function.
Background Improving health status is a fundamental goal after myocardial infarction (MI). Whether health status differs between type 1 and type 2 MI is unknown. Methods In this prospective study, 150 patients hospitalized with type 1 (n=75) and type 2 MI (n=75) were enrolled. Health status was assessed at baseline, 1, and 4 months using the EuroQol 5‐Dimension 5‐Level visual analogue scale, 7‐item Seattle Angina Questionnaire, Patient‐Reported Outcomes Measurement Information System Physical Function, Patient‐Reported Outcomes Measurement Information System Fatigue, FRAIL Scale, and Patient Health Questionnaire‐9. Results A total of 149 baseline, 92 one‐month, and 92 four‐month assessments were analyzed. Patients with type 2 MI were older, were more frequently women, and had more comorbidities. Baseline health status was similar between type 2 and type 1 MI (EuroQol 5‐Dimension 5‐Level visual analog scale, 66.20±22.17 versus 69.36±20.67; P =0.37). At 1 and 4 months, the EuroQol 5‐Dimension 5‐Level visual analog scale was lower for type 2 MI, and adjusted analyses demonstrated less improvement (difference, − 4.8 points; P =0.04). Patients with type 2 MI had lower physical function and greater frailty throughout follow‐up. Baseline fatigue and depression were similar but modestly worse for type 2 MI at follow‐up. Baseline 7‐item Seattle Angina Questionnaire scores were higher for type 2 MI but were similar between groups at follow‐up. Conclusions Although baseline overall health status was similar, patients with type 2 MI experienced smaller improvements in health status and reported a greater burden of frailty and impaired physical function over 4 months. These findings highlight the need to address health status domains beyond angina after type 2 MI.
No takes yet. Share an insight, caveat, or question.
Murphy et al. (2026) conducted a cohort in Type 1 or Type 2 Myocardial Infarction (n=149). Type 2 Myocardial Infarction vs. Type 1 Myocardial Infarction was evaluated on Change in EuroQol 5-Dimension 5-Level visual analogue scale (EQ-5D-5L VAS) from baseline to 4 months (adjusted for baseline values) (MD -4.8 points, 95% CI -9.41 to -0.29, p=0.04). Patients with type 2 MI had a smaller improvement in EQ-5D-5L VAS health status from baseline to 4 months compared with type 1 MI (adjusted difference -4.8 points; 95% CI -9.41 to -0.29; P=0.04).
Synapse has enriched 10 related papers. Consider them for comparative context: